Get started
Author

Martin Burian

Observed names: Burian, Martin, M Burian, M. Burian, M. Burian, Ch. Quint, C. Neuchrist
ORCID: 0000-0002-4099-9037
Observed ORCID: 0000-0002-4099-9037
OpenAlex ID: A5030654014
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
2019 · Barbara Burtness, Kevin J Harrington, et al. · The Lancet · 3,497
PDF
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
2024 · Jean-Pascal Machiels, Yungan Tao, et al. · The Lancet Oncology · 296
Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck
2003 · Csilla Neuchrist, Bohan M. Erovic, et al. · Head & Neck · 119
LBA5 Primary results of the phase III KEYNOTE-412 study: Pembrolizumab (pembro) with chemoradiation therapy (CRT) vs placebo plus CRT for locally advanced (LA) head and neck squamous cell carcinoma (HNSCC)
2022 · J-P. Machiels, Y. Tao, et al. · Annals of Oncology · 100
Superimposed high-frequency jet ventilation (SHFJV) for endoscopic laryngotracheal surgery in more than 1500 patients
2006 · A. Rezaie-Majd, W. Bigenzahn, et al. · British Journal of Anaesthesia · 99
PDF
Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: A double‐blind, randomized, placebo‐controlled trial
2014 · Dominik Riss, Martin Burian, et al. · Head & Neck · 84
How Do the Cervical Plexus and the Spinal Accessory Nerve Contribute to the Innervation of the Trapezius Muscle? As Seen From Within Using Sihler's Stain
2001 · Antonius C. Kierner, Irmgard Zelenka, et al. · Archives of Otolaryngology - Head and Neck Surgery · 71
Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals
1998 · Johannes Pammer, Wolfgang Weninger, et al. · The Journal of Pathology · 65
Carbocyanine Postmortem Neuronal Tracing: Influence of Different Parameters on Tracing Distance and Combination with Immunocytochemistry
1998 · Julius-Robert Lukas, Martin Aigner, et al. · Journal of Histochemistry & Cytochemistry · 65
PDF
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Expression in Squamous Cell Carcinomas of the Head and Neck
2001 · Csilla Neuchrist, Boban M. Erovic, et al. · The Laryngoscope · 64
Electroporation Therapy in Head and Neck Cancer
2003 · Martin Burian, Michael Formanek, et al. · Acta Oto-Laryngologica · 55
Motility‐related protein‐1/CD9 expression in head and neck squamous cell carcinoma
2003 · Boban M. Erovic, Johannes Pammer, et al. · Head & Neck · 45
Angiogenic Factors in Laryngeal Carcinomas: Do They Have Prognostic Relevance?
1999 · M. Burian, Ch. Quint, C. Neuchrist · Acta Oto-Laryngologica · 45
Phase II Study with Docetaxel and Cisplatin in the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
2002 · C. Gedlicka, M. Formanek, et al. · Oncology · 42
Survival of patients with HPV-positive oropharyngeal cancer after radiochemotherapy is significantly enhanced
2011 · Claudia Lill, Gabriela Kornek, et al. · Wiener klinische Wochenschrift · 29
Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck
2012 · Felix Keil, Edgar Selzer, et al. · European Journal of Cancer · 25
Mitoxantrone and cisplatin in recurrent and/or metastatic salivary gland malignancies
2002 · Claudia Gedlicka, Birgit Schüll, et al. · Anti-Cancer Drugs · 25
Quantitation of microvessel density in squamous cell carcinoma of the head and neck by computer-aided image analysis
2005 · Boban M. Erovic, Csilla Neuchrist, et al. · Wiener klinische Wochenschrift · 24
Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial
2021 · Felix Keil, Maximilian Hartl, et al. · European Journal of Cancer · 23
Nanoray-312: phase III study of NBTXR3 + radiotherapy ± cetuximab in elderly, platinum-ineligible locally advanced HNSCC
2025 · Christophe Le Tourneau, Zoltán Takácsi-Nagy, et al. · Future Oncology · 22
PDF
Carotid Resection and Reconstruction for Locally Advanced Head and Neck Tumors
2002 · Manfred Muhm, Matthaeus Ch. Grasl, et al. · Acta Oto-Laryngologica · 21
Long-term results of the randomized, phase 3 KEYNOTE-412 trial of pembrolizumab (pembro) or placebo (pbo) plus concurrent chemoradiotherapy (CRT) for unresected, locally advanced head and neck squamous cell carcinoma (LA HNSCC).
2025 · Yungan Tao, Lillian L. Siu, et al. · Journal of Clinical Oncology · 19
Influence of resection extent on morbidity in surgery for squamous cell cancer at the pharyngoesophageal junction
2012 · Peter Panhofer, Christopher Springer, et al. · Langenbeck s Archives of Surgery · 12
Salvage Therapy with Oral Etoposide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
2006 · C. Gedlicka, J. Kornfehl, et al. · Cancer Investigation · 11
880P Paclitaxel plus cetuximab for the treatment of recurrent and/or metastatic head and neck cancer after first-line checkpoint inhibitor failure: Primary analysis from the pace ace trial
2024 · T. Fuereder, K. Klinghammer, et al. · Annals of Oncology · 10
PDF
Works count: 56
Citation count: 5,215
H-index: 21
I10-index: 27
Year
Topic
Type